SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE WATIER SELARL PHARMACIE WATIER : revenue, balance sheet and financial ratios

In 2025, SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE WATIER SELARL PHARMACIE WATIER achieves revenue of 2.5 M€. Revenue is growing positively over 8 years (CAGR: +5.0%). After deducting consumption (1.9 M€), gross margin stands at 602 k€, i.e. a rate of 25%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 23 k€, representing 0.9% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 31 k€, i.e. 1.2% of revenue. This profit can be retained or distributed to shareholders.

The debt ratio (= Financial debt / Equity x 100) stands at 44%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 11.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

The liquidity ratio (= Current assets / Current liabilities) stands at 71.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 97.2x. Operating income very largely covers interest expenses: high safety margin.

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 4 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 35 days. Excellent situation: suppliers finance 31 days of the operating cycle (retail model). Inventory turnover is 21 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 23 days of revenue, i.e. 160 k€ to permanently finance. Over 2017-2025, WCR increased by +459%, requiring additional financing.

Based on 277 transactions of similar company sales in 2025, the value of SOCIETE D'EXERCICE LIBERAL A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICINE - PHARMACIE WATIER SELARL PHARMACIE WATIER is estimated at 632 255 € (range 439 763€ - 796 255€). With an EBITDA of 22 703€, the sector multiple of 7.7x is applied. The price/revenue ratio is 0.61x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.